Baricitinib Improves Bone Biomechanical Properties in Rheumatoid Arthritis (RA) - Results of a Prospective Interventional Study

Kemenes S, Hartmann F, Tascilar K, Simon D, Bayat S, Krönke G, Mendez LV, Schuster L, Liphardt AM, Schett G, Kleyer A (2022)

Publication Type: Conference contribution

Publication year: 2022

Journal

Arthritis and Rheumatology Wiley

Publisher: WILEY

City/Town: HOBOKEN

Pages Range: 3931-3933

Conference Proceedings Title: ARTHRITIS & RHEUMATOLOGY

Authors with CRIS profile

Koray Tascilar Department of Medicine 3 – Rheumatology and Immunology Sara Bayat Lehrstuhl für Innere Medizin III Gerhard Krönke Department of Medicine 3 – Rheumatology and Immunology Louis Schuster Department of Medicine 3 – Rheumatology and Immunology Anna-Maria Liphardt Department of Medicine 3 – Rheumatology and Immunology Georg Schett Lehrstuhl für Innere Medizin III Arnd Kleyer Department of Medicine 3 – Rheumatology and Immunology

How to cite

APA:

Kemenes, S., Hartmann, F., Tascilar, K., Simon, D., Bayat, S., Krönke, G.,... Kleyer, A. (2022). Baricitinib Improves Bone Biomechanical Properties in Rheumatoid Arthritis (RA) - Results of a Prospective Interventional Study. In ARTHRITIS & RHEUMATOLOGY (pp. 3931-3933). HOBOKEN: WILEY.

MLA:

Kemenes, Stephan, et al. "Baricitinib Improves Bone Biomechanical Properties in Rheumatoid Arthritis (RA) - Results of a Prospective Interventional Study." Proceedings of the ARTHRITIS & RHEUMATOLOGY HOBOKEN: WILEY, 2022. 3931-3933.

BibTeX: Download